Watt has missed the last three games after suffering a partially collapsed lung after undergoing dry needling treatment.
After additional practice participation this week, Watt expects to play, he told reporters. "I feel really good. Not sure I ...
The EVEREST-2 study reported the first complete response to CAR-T cell therapy in a non-small cell lung cancer patient.
Pittsburgh Steelers star pass rusher T.J. Watt says he's excited to return for a must-win NFL clash with Baltimore after he ...
Star missed three games after suffering a partially collapsed lung during a dry needling treatment, calling it a "fluke thing ...
The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary ...
If it weren’t for the Interventional Pulmonology team at Geisinger Medical Center and the endobronchial valve procedure, ...
Lung cancer stigma stems from its association with smoking, affecting patients' emotional well-being and support systems.
Healio Pulmonology has compiled the top news on COPD posted in 2025.Readers were most interested in how pulmonary ...
37mon MSN
Steelers LB TJ Watt calls dry needling mishap a 'fluke' and hopes to play against Baltimore
The Pittsburgh Steelers linebacker is hopeful to play on Sunday night when the Baltimore Ravens visit with the AFC North ...
Calling his ordeal “very scary” and repeatedly mentioning that he at one point was in “a significant amount of pain,” T.J.
SurvivorNet on MSN
Targeted therapy in a shot: New approval for EGFR-mutated lung cancer can improve day-to-day life for patients
Rybrevant Faspro, the new subcutaneous version of amivantamab, was approved for patients with a specific form of lung cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results